Mediating effect of vascular calcification in galectin-3-related mortality in hemodialysis patients

Abstract Galectin-3 levels have been studied as a potential biomarker for predicting cardiovascular (CV) risk and mortality in hemodialysis (HD) patients. Recently, a close relationship between galectin-3 and vascular calcification (VC) has been reported. Here, we investigated the role of VC as a me...

Full description

Bibliographic Details
Main Authors: Ji-Hwan Kim, Hye-Mi Noh, Hong Ji Song, Sion Lee, Sung Gyun Kim, Jwa-Kyung Kim
Format: Article
Language:English
Published: Nature Portfolio 2024-01-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-024-51383-2
_version_ 1797355847925366784
author Ji-Hwan Kim
Hye-Mi Noh
Hong Ji Song
Sion Lee
Sung Gyun Kim
Jwa-Kyung Kim
author_facet Ji-Hwan Kim
Hye-Mi Noh
Hong Ji Song
Sion Lee
Sung Gyun Kim
Jwa-Kyung Kim
author_sort Ji-Hwan Kim
collection DOAJ
description Abstract Galectin-3 levels have been studied as a potential biomarker for predicting cardiovascular (CV) risk and mortality in hemodialysis (HD) patients. Recently, a close relationship between galectin-3 and vascular calcification (VC) has been reported. Here, we investigated the role of VC as a mediating factor in the association between galectin-3 and mortality. Serum galectin-3 and baseline aortic arch calcification (AoAC) score were measured in 477 incident HD patients. Mortality data were obtained at a median follow-up of 40 months. Causal mediation analysis was performed to examine the effect of vascular risk factors on galectin-3-related mortality. The prevalence of AoAC in HD patients was 57% (n = 272), and elevated galectin-3 levels were associated with a significantly increased risk of AoAC. When the galectin-3 level was divided by the median level of 37 ng/mL, a higher galectin group increased the risk of all-cause mortality by 1.71-fold (95% CI 1.02–2.92, p = 0.048), even after adjustment for multiple CV risk factors. Mediation analysis showed that both the direct effect of the galectin-3 on mortality (β = 0.0368, bootstrapped 95% CI [0.0113–0.0622]) and the indirect effects were significant. AoAC score and high-sensitivity CRP levels significantly mediated the association between galectin-3 and mortality (total indirect effects: β = 0.0188, bootstrapped 95% CI [0.0066–0.0352]). This study suggests that the association between high galectin-3 and mortality may be partially mediated by higher VC and inflammatory state in HD patients.
first_indexed 2024-03-08T14:17:03Z
format Article
id doaj.art-477770e7784d4044bbffb93775186362
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-03-08T14:17:03Z
publishDate 2024-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-477770e7784d4044bbffb937751863622024-01-14T12:19:06ZengNature PortfolioScientific Reports2045-23222024-01-0114111010.1038/s41598-024-51383-2Mediating effect of vascular calcification in galectin-3-related mortality in hemodialysis patientsJi-Hwan Kim0Hye-Mi Noh1Hong Ji Song2Sion Lee3Sung Gyun Kim4Jwa-Kyung Kim5Department of Internal Medicine and Kidney Research Institute, Hallym University Sacred Heart HospitalDepartment of Family Medicine, Hallym University Sacred Heart HospitalDepartment of Family Medicine, Hallym University Sacred Heart HospitalDepartment of Statistics and Institute of Statistics, Hallym UniversityDepartment of Internal Medicine and Kidney Research Institute, Hallym University Sacred Heart HospitalDepartment of Internal Medicine and Kidney Research Institute, Hallym University Sacred Heart HospitalAbstract Galectin-3 levels have been studied as a potential biomarker for predicting cardiovascular (CV) risk and mortality in hemodialysis (HD) patients. Recently, a close relationship between galectin-3 and vascular calcification (VC) has been reported. Here, we investigated the role of VC as a mediating factor in the association between galectin-3 and mortality. Serum galectin-3 and baseline aortic arch calcification (AoAC) score were measured in 477 incident HD patients. Mortality data were obtained at a median follow-up of 40 months. Causal mediation analysis was performed to examine the effect of vascular risk factors on galectin-3-related mortality. The prevalence of AoAC in HD patients was 57% (n = 272), and elevated galectin-3 levels were associated with a significantly increased risk of AoAC. When the galectin-3 level was divided by the median level of 37 ng/mL, a higher galectin group increased the risk of all-cause mortality by 1.71-fold (95% CI 1.02–2.92, p = 0.048), even after adjustment for multiple CV risk factors. Mediation analysis showed that both the direct effect of the galectin-3 on mortality (β = 0.0368, bootstrapped 95% CI [0.0113–0.0622]) and the indirect effects were significant. AoAC score and high-sensitivity CRP levels significantly mediated the association between galectin-3 and mortality (total indirect effects: β = 0.0188, bootstrapped 95% CI [0.0066–0.0352]). This study suggests that the association between high galectin-3 and mortality may be partially mediated by higher VC and inflammatory state in HD patients.https://doi.org/10.1038/s41598-024-51383-2
spellingShingle Ji-Hwan Kim
Hye-Mi Noh
Hong Ji Song
Sion Lee
Sung Gyun Kim
Jwa-Kyung Kim
Mediating effect of vascular calcification in galectin-3-related mortality in hemodialysis patients
Scientific Reports
title Mediating effect of vascular calcification in galectin-3-related mortality in hemodialysis patients
title_full Mediating effect of vascular calcification in galectin-3-related mortality in hemodialysis patients
title_fullStr Mediating effect of vascular calcification in galectin-3-related mortality in hemodialysis patients
title_full_unstemmed Mediating effect of vascular calcification in galectin-3-related mortality in hemodialysis patients
title_short Mediating effect of vascular calcification in galectin-3-related mortality in hemodialysis patients
title_sort mediating effect of vascular calcification in galectin 3 related mortality in hemodialysis patients
url https://doi.org/10.1038/s41598-024-51383-2
work_keys_str_mv AT jihwankim mediatingeffectofvascularcalcificationingalectin3relatedmortalityinhemodialysispatients
AT hyeminoh mediatingeffectofvascularcalcificationingalectin3relatedmortalityinhemodialysispatients
AT hongjisong mediatingeffectofvascularcalcificationingalectin3relatedmortalityinhemodialysispatients
AT sionlee mediatingeffectofvascularcalcificationingalectin3relatedmortalityinhemodialysispatients
AT sunggyunkim mediatingeffectofvascularcalcificationingalectin3relatedmortalityinhemodialysispatients
AT jwakyungkim mediatingeffectofvascularcalcificationingalectin3relatedmortalityinhemodialysispatients